![](/img/cover-not-exists.png)
Anacetrapib reduces (V)LDL cholesterol by inhibition of CETP activity and reduction of plasma PCSK9
van der Tuin, Sam J. L., Kühnast, Susan, Berbée, Jimmy F. P., Verschuren, Lars, Pieterman, Elsbet J., Havekes, Louis M., van der Hoorn, José W. A., Rensen, Patrick C. N., Jukema, J. Wouter, Princen, HVolume:
56
Language:
english
Journal:
Journal of Lipid Research
DOI:
10.1194/jlr.M057794
Date:
November, 2015
File:
PDF, 1006 KB
english, 2015